Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma | British Journal of Cancer
Novel Therapies Targeting FGFR-Altered Advanced Cholangiocarcinoma
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype | JCO Precision Oncology
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype | JCO Precision Oncology
Clinical trials of FGF/FGFR signaling-targeted therapies for CCA. | Download Scientific Diagram
Figure 2 from Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma | Semantic Scholar
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype | JCO Precision Oncology
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype | JCO Precision Oncology
IJMS | Free Full-Text | FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention | HTML
Frontiers | Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer | Oncology
Molecular targeted therapies: Ready for “prime time” in biliary tract cancer - Journal of Hepatology
Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy
FGFR2 genomic aberrations: Achilles heel in the management of advanced cholangiocarcinoma - Cancer Treatment Reviews
JCM | Free Full-Text | Molecular Profiling in Daily Clinical Practice: Practicalities in Advanced Cholangiocarcinoma and Other Biliary Tract Cancers | HTML
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype | JCO Precision Oncology
Incorporating FGFR Inhibitors into the Treatment Paradigm for Cholangiocarcinoma: Current Concepts and Future Directions - CCA News Online | CCA News Online
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma | British Journal of Cancer
Advances and challenges in targeting FGFR signalling in cancer | Nature Reviews Cancer
Schematic representation of commonly found FGFR2 fusion proteins in... | Download Scientific Diagram
Cancers | Free Full-Text | Targeting the Fibroblast Growth Factor Receptor ( FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations | HTML
Incorporating FGFR Inhibitors into the Treatment Paradigm for Cholangiocarcinoma: Current Concepts and Future Directions - CCA News Online | CCA News Online
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study - The Lancet Oncology
Frontiers | Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type | Genetics
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype | JCO Precision Oncology
